Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
RD133
/
IASO BIO
Welcome,
Profile
Billing
Logout
Diseases
Trials
Trials
News
|
|||||||||
RD133
/
IASO BIO
Enrollment open:
Safety and Efficacy of RD133 in Subjects With Relapsed or Refractory MSLN-Positive Solid Tumors
(clinicaltrials.gov) - Apr 26, 2022
P1
, N=24, Recruiting,
Sponsor: Tongji Hospital
Not yet recruiting --> Recruiting
|
|||||||||
RD133
/
IASO BIO
New P1 trial:
An Exploratory Clinical Study of RD133 in Subjects With Relapsed or Refractory MSLN-Positive Solid Tumors
(clinicaltrials.gov) - Dec 21, 2021
P1
, N=24, Recruiting,
Sponsor: The First Affiliated Hospital with Nanjing Medical University
|
|||||||||
RD133
/
IASO BIO
New P1 trial:
Safety and Efficacy of RD133 in Subjects With Relapsed or Refractory MSLN-Positive Solid Tumors
(clinicaltrials.gov) - Dec 2, 2021
P1
, N=24, Not yet recruiting,
Sponsor: Tongji Hospital